Israel shows what a post-COVID future looks like

Advertisement

Life in Israel is quickly returning back to ‘normal’ amid mass vaccination of its population with the Pfizer vaccine.

Two-thirds of Israelis have received at least one dose of the Pfizer vaccine:

Israel vaccination

Two-thirds of Israelis have received at least one shot of Pfizer.

Whereas 60% of Israelis have been fully vaccinated with two shots:

Advertisement
Israel full vaccination

60% of Israelis fully vaccinated.

With herd immunity beckoning, the Israeli Government has greatly loosened restrictions and allowed mass gatherings across the nation state:

  • Last week, tens of thousands flocked to the beachfront in Tel Aviv for a LGBTQ pride parade without masks, singing, dancing and sometimes hugging and kissing.
  • Most of the economy remains open and Israelis can even travel overseas, although they were being encouraged to avoid it.
  • “The vaccinated people who are infected are almost never hospitalised,” said Professor Nadav Davidovitch, an infectious diseases specialist from Ben Gurion University. “You have a reduction [in severe cases] of 90 to 95 per cent.”
Advertisement

Case numbers are beginning to rise, however, owing to the spread of the Delta variant. And this has prompted the Israeli Government to impose an indoor mask mandate to protect the unvaccinated.

Israel COVID cases

Cases rising again.

Nevertheless, Israel’s high vaccination rate has lowered hospitalisation rates:

Advertisement
Israel COVID patients

But no overburdened hospitals.

There is also hardly anybody in ICU with COVID:

Israel ICU

Not so deadly.

COVID deaths are also almost non-existent:

Israel COVID deaths

No COVID grim reaper.

In short, Israel gives us a glimpse of the post-COVID future once the majority of the population is fully vaccinated.

Advertisement
About the author
Leith van Onselen is Chief Economist at the MB Fund and MB Super. He is also a co-founder of MacroBusiness. Leith has previously worked at the Australian Treasury, Victorian Treasury and Goldman Sachs.